VEGF Signal Complexity Confers Resistance to Atezolizumab, Bevacizumab, Carboplatin, and Paclitaxel in EGFR-Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer. - Hong S; Yu N; Cho JY; Lee GK; Ahn BC; Lee Y; Sim H; Song BR; Hwang M; Kim S; Kim JH; Park C; et al. (MedComm, 2025)